Literature DB >> 10050667

The CTLA-4 gene is expressed in placental fibroblasts.

K A Kaufman1, J A Bowen, A F Tsai, J A Bluestone, J S Hunt, C Ober.   

Abstract

In order to elucidate the mechanisms that ensure survival of the allogeneic fetus, we are investigating the expression pattern of genes that are involved in peripheral self-tolerance in tissues at the maternal-fetal interface. Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) is a negative regulator of T cell activation and may modulate peripheral self-tolerance. Previously, we reported the preferential transmission of maternally-inherited shorter alleles at a 3'-UTR microsatellite locus to liveborn children, but random transmission of paternally-inherited alleles, suggesting that CTLA-4 may be involved in the maintenance of tolerance at the maternal-fetal interface. In this report, we demonstrate that CTLA-4 mRNA and protein are indeed expressed in fetal tissues at the maternal-fetal interface throughout gestation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10050667     DOI: 10.1093/molehr/5.1.84

Source DB:  PubMed          Journal:  Mol Hum Reprod        ISSN: 1360-9947            Impact factor:   4.025


  21 in total

1.  Clinical Implications of Cytotoxic T Lymphocyte Antigen-4 Expression on Tumor Cells and Tumor-Infiltrating Lymphocytes in Extrahepatic Bile Duct Cancer Patients Undergoing Surgery Plus Adjuvant Chemoradiotherapy.

Authors:  Yu Jin Lim; Jaemoon Koh; Kyubo Kim; Eui Kyu Chie; Sehui Kim; Kyoung Bun Lee; Jin-Young Jang; Sun Whe Kim; Do-Youn Oh; Yung-Jue Bang
Journal:  Target Oncol       Date:  2017-04       Impact factor: 4.493

Review 2.  Immunotherapy and hypophysitis: clinical presentation, treatment, and biologic insights.

Authors:  Alexander Faje
Journal:  Pituitary       Date:  2016-02       Impact factor: 4.107

Review 3.  B7 family molecules as regulators of the maternal immune system in pregnancy.

Authors:  Margaret G Petroff; Antoine Perchellet
Journal:  Am J Reprod Immunol       Date:  2010-04-08       Impact factor: 3.886

4.  Force-dependent trans-endocytosis by breast cancer cells depletes costimulatory receptor CD80 and attenuates T cell activation.

Authors:  Seungman Park; Yu Shi; Byoung Choul Kim; Myung Hyun Jo; Leilani O Cruz; Zheming Gou; Taekjip Ha; Li-Fan Lu; Daniel H Reich; Yun Chen
Journal:  Biosens Bioelectron       Date:  2020-06-17       Impact factor: 10.618

Review 5.  Check Point Inhibitors and Their Role in Immunosuppression in Sepsis.

Authors:  Michelle E Wakeley; Chyna C Gray; Sean F Monaghan; Daithi S Heffernan; Alfred Ayala
Journal:  Crit Care Clin       Date:  2019-10-21       Impact factor: 3.598

6.  Maternally transmitted severe glucose 6-phosphate dehydrogenase deficiency is an embryonic lethal.

Authors:  Letizia Longo; Olga Camacho Vanegas; Meghavi Patel; Vittorio Rosti; Haiqing Li; John Waka; Taha Merghoub; Pier Paolo Pandolfi; Rosario Notaro; Katia Manova; Lucio Luzzatto
Journal:  EMBO J       Date:  2002-08-15       Impact factor: 11.598

7.  Phenotypic characterization of regulatory T cells in the human decidua.

Authors:  J Heikkinen; M Möttönen; A Alanen; O Lassila
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

Review 8.  Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family.

Authors:  Frank A Schildberg; Sarah R Klein; Gordon J Freeman; Arlene H Sharpe
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

Review 9.  Cancer Immunotherapy: Factors Important for the Evaluation of Safety in Nonclinical Studies.

Authors:  Danuta J Herzyk; Helen G Haggerty
Journal:  AAPS J       Date:  2018-02-07       Impact factor: 4.009

10.  The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-α production.

Authors:  Stefania Laurent; Paola Queirolo; Silvia Boero; Sandra Salvi; Patrizia Piccioli; Simona Boccardo; Simona Minghelli; Anna Morabito; Vincenzo Fontana; Gabriella Pietra; Paolo Carrega; Nicoletta Ferrari; Francesca Tosetti; Lung-Ji Chang; Maria Cristina Mingari; Guido Ferlazzo; Alessandro Poggi; Maria Pia Pistillo
Journal:  J Transl Med       Date:  2013-05-01       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.